Chinese seed enterprises and state institutions are rapidly achieving technological self-reliance, breaking longstanding foreign monopolies across genotyping chips, genetically modified traits, and artificial intelligence-driven breeding platforms. Domestic genotyping chips developed by firms like Suzhou Laso Biotech and MolBreeding have displaced imports from U.S. suppliers such as Illumina and Thermo Fisher Scientific, while Ministry of Commerce restrictions and intellectual property policies consolidate the domestic market.
Simultaneously, genetically modified crops such as corn and soybeans rely exclusively on indigenous traits, with foreign competitors barred from domestic cultivation by negative lists and biosafety regulations. State-backed initiatives integrate artificial intelligence and streamlined gene-editing approvals into commercial pipelines, positioning domestic developers to expand their footprint internationally across major agricultural markets.
Beijing prioritises indigenous control over agricultural input supply chains to insulate strategic commodity production from external technological dependencies. The commercial integration of solid-phase genotyping chips from Suzhou Laso Biotech alongside Cas12-family editing tools mirrors state-directed import substitution efforts observed across critical technology sectors. By legally excluding foreign entities from genetically modified crop cultivation and deploying accelerated biosafety approval pathways, the Ministry of Agriculture and Rural Affairs establishes a structurally protected domestic biotechnology base.
No comments:
Post a Comment